These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8933042)

  • 1. Statistical methods for the blood beryllium lymphocyte proliferation test.
    Frome EL; Smith MH; Littlefield LG; Neubert RL; Colyer SP
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):957-68. PubMed ID: 8933042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an abnormal beryllium lymphocyte proliferation test.
    Frome EL; Newman LS; Cragle DL; Colyer SP; Wambach PF
    Toxicology; 2003 Feb; 183(1-3):39-56. PubMed ID: 12504341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the blood beryllium lymphocyte proliferation test.
    Newman LS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):953-6. PubMed ID: 8933041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rocky Flats Beryllium Health Surveillance.
    Stange AW; Furman FJ; Hilmas DE
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):981-6. PubMed ID: 8933045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity.
    Milovanova TN
    Cytometry B Clin Cytom; 2007 Jul; 72(4):265-75. PubMed ID: 17328032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BeLPT: algorithms and implications.
    Middleton DC; Lewin MD; Kowalski PJ; Cox SS; Kleinbaum D
    Am J Ind Med; 2006 Jan; 49(1):36-44. PubMed ID: 16362939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory factors contributing to uninterpretable beryllium lymphocyte proliferation tests (BeLPT).
    Smith DE; Golden AP; Stange AW; Barker E; Mroz M; Barón AE; Ghosh D; Maier L; Cragle D; Newman LS
    Am J Ind Med; 2018 Jul; 61(7):592-604. PubMed ID: 29574954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing BeLPT criteria for beryllium sensitization.
    Middleton DC; Fink J; Kowalski PJ; Lewin MD; Sinks T
    Am J Ind Med; 2008 Mar; 51(3):166-72. PubMed ID: 18181198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in identifying beryllium sensitization and disease.
    Middleton D; Kowalski P
    Int J Environ Res Public Health; 2010 Jan; 7(1):115-24. PubMed ID: 20195436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test.
    Amicosante M; Deubner D; Saltini C
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):175-9. PubMed ID: 16315779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant.
    Newman LS; Mroz MM; Maier LA; Daniloff EM; Balkissoon R
    J Occup Environ Med; 2001 Mar; 43(3):231-7. PubMed ID: 11285871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
    Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
    Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic beryllium disease among dental technicians in Israel.
    Fireman E; Kramer MR; Priel I; Lerman Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Oct; 23(3):215-21. PubMed ID: 18038921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpreting borderline BeLPT results.
    Middleton DC; Mayer AS; Lewin MD; Mroz MM; Maier LA
    Am J Ind Med; 2011 Mar; 54(3):205-9. PubMed ID: 20957676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: an evidence-based assessment.
    Borak J; Woolf SH; Fields CA
    J Occup Environ Med; 2006 Sep; 48(9):937-47. PubMed ID: 16966961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch LS; Ringen K; Dement J; Bingham E; Quinn P; Shorter J; Fisher M
    Am J Ind Med; 2013 Oct; 56(10):1125-36. PubMed ID: 23794247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beryllium health effects in the era of the beryllium lymphocyte proliferation test.
    Maier LA
    Appl Occup Environ Hyg; 2001 May; 16(5):514-20. PubMed ID: 11370931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beryllium BioBank: 2. Lymphocyte proliferation testing.
    Harber P; Su J; Alongi G
    J Occup Environ Med; 2014 Aug; 56(8):857-60. PubMed ID: 25099413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of beryllium lymphocyte transformation tests in chronic beryllium disease.
    Williams WR; Williams WJ
    Int Arch Allergy Appl Immunol; 1982; 67(2):175-80. PubMed ID: 7056594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.